Digital Ally (DGLY) Stock Price, News & Analysis

Digital Ally's stock was trading at $2.12 at the beginning of the year. Since then, DGLY stock has increased by 1.4% and is now trading at $2.15.
View the best growth stocks for 2024 here.

Digital Ally saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 147,800 shares, a drop of 5.6% from the March 15th total of 156,600 shares. Based on an average daily volume of 13,500 shares, the short-interest ratio is presently 10.9 days. Currently, 5.7% of the shares of the company are sold short.
View Digital Ally's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our DGLY earnings forecast.

Digital Ally, Inc. (NASDAQ:DGLY) issued its quarterly earnings results on Wednesday, November, 17th. The scientific and technical instruments company reported $3.20 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.80) by $4.00. The scientific and technical instruments company had revenue of $4.64 million for the quarter. Digital Ally had a negative trailing twelve-month return on equity of 123.47% and a negative net margin of 90.01%.

Shares of Digital Ally reverse split on the morning of Tuesday, February 7th 2023. The 1-20 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

16 employees have rated Digital Ally Chief Executive Officer Stanton E. Ross on Glassdoor.com. Stanton E. Ross has an approval rating of 44% among the company's employees. This puts Stanton E. Ross in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Digital Ally investors own include Advanced Micro Devices (AMD), Co-Diagnostics (CODX), iBio (IBIO), Micron Technology (MU), Pfizer (PFE), Tonix Pharmaceuticals (TNXP), Biocept (BIOC), FuelCell Energy (FCEL) and Inovio Pharmaceuticals (INO).

Shares of DGLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.